跳至主要内容
临床试验/NCT07534280
NCT07534280已完成不适用

Efficacy of Berry Leaves & Mango Leaves Mixture in Symptomatic Treatments on Disease-related Quality of Life in Adults With Clinically Diagnosed Acute Rhinosinusitis

Deraya University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年11月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Reduction of SNOT 16 score after treatment

研究概览

简要总结

The objective of this phase I controlled clinical trial is to determine the safety and efficacy of Berry leaves & Mango leaves mixture in symptomatic treatments on disease-related quality of life in adults with clinically diagnosed acute rhinosinusitis. Ten adult subjects, 18 to 70 years old, who meet the recommended criteria for acute rhinosinusitis, will be enrolled from Minia university ENT outpatient Clinic. Subjects will be advised to add Berry leaves & Mango leaves herbal tea mixture and followed for one month with their routine therapy (an oral decongestant, a nasal saline spray, and an antitussive agent except analgesic). Subject outcomes will be assessed by telephone interview at 0, 3, 7, 10, and 28 days. The Quality-of-life outcomes are measured on Day 3, 10 and 28 with SNOT-16, a validated evaluative instrument.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • The subject must have symptoms of acute bacterial rhinosinusitis.
  • The subject should be able to be self-assessed as moderate, severe, or very severe.
  • The subject must have access to a phone.
  • The subject must accept sharing and sign consent.
  • The subject should follow instructions carefully and not miss times of assessment

排除标准

  • The subject has an allergy to: Flavonoids, phenolic acids, anthocyanins, carotenoids.
  • The subject has complications of sinusitis (facial edema, cellulitis, or orbital, meningeal or cerebral signs).
  • The subject is pregnancy.
  • The subject has a comorbidity that may impair their immune response (such as immunodeficiency disease, uncontrolled cancer, or chemotherapy or radiation treatment).
  • The subject has cystic fibrosis

研究组 & 干预措施

Routine therapy

Active Comparator

Steroid plus oral antibiotics in their normal doses

干预措施: local steroids (Drug)

Routine therapy

Active Comparator

Steroid plus oral antibiotics in their normal doses

干预措施: amoxicillin clavulanates (Drug)

Nasal irrigation Plus antibiotic

Placebo Comparator

Nasal irrigation daily Plus oral antibiotics

干预措施: amoxicillin clavulanates (Drug)

Nasal irrigation Plus antibiotic

Placebo Comparator

Nasal irrigation daily Plus oral antibiotics

干预措施: nasal saline (Other)

herbal tea group

Experimental

Herbal tea 3 mgs three times a day plus oral antibiotic

干预措施: mango leaves extract (Dietary Supplement)

herbal tea group

Experimental

Herbal tea 3 mgs three times a day plus oral antibiotic

干预措施: amoxicillin clavulanates (Drug)

结局指标

主要结局

Reduction of SNOT 16 score after treatment

时间窗: 14 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soad Ali

associate professor

Deraya University

研究点 (2)

Loading locations...

相似试验